These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 14638514)
41. Voriconazole in the treatment of invasive mold infections in transplant recipients. Fortún J; Martín-Dávila P; Sánchez MA; Pintado V; Alvarez ME; Sánchez-Sousa A; Moreno S Eur J Clin Microbiol Infect Dis; 2003 Jul; 22(7):408-13. PubMed ID: 12827536 [TBL] [Abstract][Full Text] [Related]
42. Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia. Przepiorka D; Buadi FK; McClune B Pharmacotherapy; 2008 Jan; 28(1):58-63. PubMed ID: 18154475 [TBL] [Abstract][Full Text] [Related]
43. Scedosporium apiospermum soft tissue infection as the initial presentation of acute myeloid leukemia: a case report. Allen PB; Koka R; Kleinberg ME; Baer MR J Clin Oncol; 2013 Mar; 31(7):e98-100. PubMed ID: 23319688 [No Abstract] [Full Text] [Related]
44. Scedosporium apiospermum skeletal infection in an immunocompetent child. Stripeli F; Pasparakis D; Velegraki A; Lebessi E; Arsenis G; Kafetzis D; Tsolia M Med Mycol; 2009 Jun; 47(4):441-4. PubMed ID: 19191169 [TBL] [Abstract][Full Text] [Related]
45. Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia. Fournier S; Pavageau W; Feuillhade M; Deplus S; Zagdanski AM; Verola O; Dombret H; Molina JM Eur J Clin Microbiol Infect Dis; 2002 Dec; 21(12):892-6. PubMed ID: 12525928 [TBL] [Abstract][Full Text] [Related]
46. Case of cutaneous Scedosporium apiospermum infection successfully treated with voriconazole. Matsumoto Y; Oh-I T; Nagai A; Ohyama F; Ooishi T; Tsuboi R J Dermatol; 2009 Feb; 36(2):98-102. PubMed ID: 19284454 [TBL] [Abstract][Full Text] [Related]
47. Disseminated Scedosporium apiospermum infection in renal transplant recipient: long-term successful treatment with voriconazole: a case report. Rogasi PG; Zanazzi M; Nocentini J; Fantoni E; Trotta M; Faggi E; Fontanelli A; Bertoni E; Salvadori M; Leoncini F Transplant Proc; 2007; 39(6):2033-5. PubMed ID: 17692684 [TBL] [Abstract][Full Text] [Related]
48. Activity of voriconazole against corneal isolates of Scedosporium apiospermum. Shah KB; Wu TG; Wilhelmus KR; Jones DB Cornea; 2003 Jan; 22(1):33-6. PubMed ID: 12502945 [TBL] [Abstract][Full Text] [Related]
49. Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections. Cecil JA; Wenzel RP Expert Rev Hematol; 2009 Jun; 2(3):237-54. PubMed ID: 21082966 [TBL] [Abstract][Full Text] [Related]
50. Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report. Kesson AM; Bellemore MC; O'Mara TJ; Ellis DH; Sorrell TC Clin Infect Dis; 2009 May; 48(9):1257-61. PubMed ID: 19320594 [TBL] [Abstract][Full Text] [Related]
51. Keratitis caused by Scedosporium apiospermum successfully treated with a cornea transplant and voriconazole. Nulens E; Eggink C; Rijs AJ; Wesseling P; Verweij PE J Clin Microbiol; 2003 May; 41(5):2261-4. PubMed ID: 12734297 [TBL] [Abstract][Full Text] [Related]
52. Efficacy of voriconazole in treatment of murine pulmonary blastomycosis. Sugar AM; Liu XP Antimicrob Agents Chemother; 2001 Feb; 45(2):601-4. PubMed ID: 11158762 [TBL] [Abstract][Full Text] [Related]
53. Efficacy of voriconazole for Scedosporium apiospermum skull base osteomyelitis: case report and literature review. Vasoo S; Yeo SB; Lim PL; Ang BS; Lye DC Int J Antimicrob Agents; 2008 Feb; 31(2):184-5. PubMed ID: 18083011 [No Abstract] [Full Text] [Related]
54. Use of intralesional voriconazole for the treatment of cutaneous Scedosporium apiospermum infection. Azofra MM; Somovilla JL; Porras MC; Carrillo LH; Pérez RD Clin Infect Dis; 2010 Jul; 51(2):255-7. PubMed ID: 20560740 [No Abstract] [Full Text] [Related]
55. Voriconazole versus amphotericin B in cancer patients with neutropenia. Jørgensen KJ; Gøtzsche PC; Johansen HK Cochrane Database Syst Rev; 2006 Jan; (1):CD004707. PubMed ID: 16437492 [TBL] [Abstract][Full Text] [Related]
56. Antifungal therapy in a murine model of disseminated infection by Cryptococcus gattii. Calvo E; Pastor FJ; Rodríguez MM; Pujol I; Guarro J Antimicrob Agents Chemother; 2010 Oct; 54(10):4074-7. PubMed ID: 20625150 [TBL] [Abstract][Full Text] [Related]
57. Scedosporium prolificans pericarditis and mycotic aortic aneurysm in a lung transplant recipient receiving voriconazole prophylaxis. Sayah DM; Schwartz BS; Kukreja J; Singer JP; Golden JA; Leard LE Transpl Infect Dis; 2013 Apr; 15(2):E70-4. PubMed ID: 23387799 [TBL] [Abstract][Full Text] [Related]
58. Efficacy of triazoles in a murine disseminated infection by Candida krusei. Mariné M; Pastor FJ; Serena C; Guarro J Antimicrob Agents Chemother; 2009 Aug; 53(8):3585-8. PubMed ID: 19470509 [TBL] [Abstract][Full Text] [Related]
59. Voriconazole in fungal keratitis caused by Scedosporium apiospermum. Hernández Prats C; Llinares Tello F; Burgos San José A; Selva Otaolaurruchi J; Ordovás Baines JP Ann Pharmacother; 2004 Mar; 38(3):414-7. PubMed ID: 14755065 [TBL] [Abstract][Full Text] [Related]
60. Combined therapies in a murine model of blastoschizomycosis. Serena C; Rodríguez MM; Mariné M; Pastor FJ; Guarro J Antimicrob Agents Chemother; 2007 Jul; 51(7):2608-10. PubMed ID: 17452487 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]